Clinical trial
Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be…
NCT00003649 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003649 |
|---|---|
| Title | Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed |
| Official title | Phase I Pilot Trial of Adenovirus p53 in Bronchioloalveolar Cell Lung Carcinoma (BAC) Administered by Bronchoalveolar Lavage |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological |
| Interventions | Ad5CMV-p53 gene |
| Start date | Nov 17, 1998 |
| Completion | Jun 15, 2007 |
| First posted | Apr 30, 2003 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: